FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Research!America Seeks $200 Million Boost in FDA Funding

[ Price : $8.95]

Research!America urges the U.S. House and Senate Appropriations Subcommittees to provide FDA at least a $200 million increase in i...

Dental Amalgam Leads to Higher Risk of Alzheimers: Study

[ Price : $8.95]

A new study finds that individuals exposed to dental amalgam fillings had higher risk of Alzheimers disease than their non-exposed...

Spectral Files 3rd PMA Module for Septic Shock Treatment

[ Price : $8.95]

Spectral Medical files the third module of a rolling PMA submission for its Toraymyxin hemoperfusion cartridge for treating patien...

Dr. Reddys Loses in Court Over Purple Generic Nexium

[ Price : $8.95]

A Delaware federal judge issues a temporary restraining order against Dr. Reddys Laboratories blocking the companys sales of a gen...

New Colombia Partners With AiP on Cannabinoid

[ Price : $8.95]

New Colombia Resources says it is partnering with Advanced Imaging Projects on developing and accelerating regulatory agency appro...

Qualified Infectious Disease Product Status for Destiny Drug

[ Price : $8.95]

FDA grants Destiny Pharma a Qualified Infectious Disease Product designation for the XF-73 (exeporfinium chloride) and its use in ...

Panel to Review Merck NDA Supplements for Ezetimibe

[ Price : $8.95]

FDAs Endocrinologic and Metabolic Drugs Advisory Committee plans to review Mercks IMPROVE-IT trial and its support of supplemental...

NeuroDerm Modifies Parkinsons Trials After FDA Feedback

[ Price : $8.95]

NeuroDerm modifies its U.S. development plan for ND0612H and ND0612L, the companys continuous, subcutaneously delivered levodopa/c...

Neos Complete Response Seeks Additional Data on ADHD Drug

[ Price : $8.95]

FDA issues Neos Therapeutics a complete response letter on the companys NDA for Cotempla XR-ODT (methylphenidate extended release ...

FDA Clears Deerfield Imaging Brain Biopsy System

[ Price : $8.95]

FDA clears a Deerfield Imaging 510(k) to market its SYMBIS stereotactic brain biopsy system in the U.S.